End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,520 KRW | -0.29% | -0.95% | -5.45% |
Business Summary
Number of employees: 937
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Merchandise
50.8
%
| 273,963 | 50.4 % | 265,597 | 50.8 % | -3.05% |
Pharmaceutical Product
42.7
%
| 235,923 | 43.4 % | 223,460 | 42.7 % | -5.28% |
Other
5.6
%
| 33,873 | 6.2 % | 29,518 | 5.6 % | -12.86% |
Lease
0.8
%
| - | - | 4,166 | 0.8 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
97.4
%
| 516,088 | 94.9 % | 509,333 | 97.4 % | -1.31% |
International
2.6
%
| 27,671 | 5.1 % | 13,408 | 2.6 % | -51.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeong-Yeol Jo
CEO | Chief Executive Officer | 57 | - |
Young-Jin Kim
CEO | Chief Executive Officer | 67 | 83-12-31 |
Seong-Joon Hong
DFI | Director of Finance/CFO | 59 | 17-04-20 |
Hyun-Ik Kim
BRD | Director/Board Member | 62 | - |
Chul-Joon Kim
BRD | Director/Board Member | 71 | 09-03-12 |
In-Je Hwang
SAM | Sales & Marketing | 61 | - |
Young Kim
LAW | General Counsel | 56 | - |
Eun-Joo Kim
PRN | Corporate Officer/Principal | 54 | - |
Eun-Yeong Choi
PRN | Corporate Officer/Principal | 55 | - |
Jin-Ki Baik
HRO | Human Resources Officer | 66 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Jin Kim
CEO | Chief Executive Officer | 67 | 83-12-31 |
Chul-Joon Kim
BRD | Director/Board Member | 71 | 09-03-12 |
Hyun-Ik Kim
BRD | Director/Board Member | 62 | - |
Won-Ho Kim
BRD | Director/Board Member | 68 | 14-03-13 |
Young-Geo Seo
BRD | Director/Board Member | 72 | 15-03-26 |
Jeong-Yeol Jo
CEO | Chief Executive Officer | 57 | - |
Chang-Yul Kang
BRD | Director/Board Member | 70 | 20-03-18 |
Chan-Hee Han
BRD | Director/Board Member | 69 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,763,533 | 7,783,419 ( 56.55 %) | 0 | 56.55 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GENEXINE, INC. 14.57% | 6,048,534 | 14.57% | 32,866,282 $ |
REZOLUTE, INC. 14.81% | 5,942,617 | 14.81% | 15,450,804 $ |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.45% | 137M | |
+37.78% | 723B | |
+31.16% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.58% | 244B | |
-4.62% | 208B | |
+10.03% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- A002390 Stock
- Company HANDOK Inc.